We’re delighted to add a summary of a webinar event on the use of Cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma.
The presenter, Professor Danny Rischin, is a medical oncologist/clinician researcher at the Peter MacCallum Cancer Centre and presented on the current treatment landscape, key studies supporting the use of Cemiplimab and a series of patient case studies.
Please login below to download this issue (PDF)